References
Works cited across the glossary and the traces, in APA (7th edition). Every in-text citation on the site links here and shows the full entry on hover or tap.
Abadie, A., Diamond, A., & Hainmueller, J. (2010). Synthetic control methods for comparative case studies: Estimating the effect of California’s tobacco control program. Journal of the American Statistical Association, 105(490), 493–505. https://doi.org/10.1198/jasa.2009.ap08746
ACCORD Study Group (2010). Effects of intensive blood-pressure control in type 2 diabetes mellitus. New England Journal of Medicine, 362(17), 1575–1585. https://doi.org/10.1056/NEJMoa1001286
Akaike, H. (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19(6), 716–723. https://doi.org/10.1109/tac.1974.1100705
Alonso-Coello, P., Schünemann, H. J., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Rada, G., Rosenbaum, S., Morelli, A., Guyatt, G. H., & Oxman, A. D. (2016). GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ, 353, i2016. https://doi.org/10.1136/bmj.i2016
Angrist, J. D., Imbens, G. W., & Rubin, D. B. (1996). Identification of causal effects using instrumental variables. Journal of the American Statistical Association, 91(434), 444–455. https://doi.org/10.1080/01621459.1996.10476902
Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B: Statistical Methodology, 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 327(8476), 307–310. https://doi.org/10.1016/s0140-6736(86)90837-8
Bo, Y., Kwok, K. O., Chu, K. K. Y., Leung, E. Y. H., Yu, C. P., Wong, S. Y. S., & Lee, E. K. P. (2021). Comparison between automated office blood pressure measurements and manual office blood pressure measurements—Implications in individual patients: A systematic review and meta-analysis. Current Hypertension Reports, 23(1). https://doi.org/10.1007/s11906-020-01118-1
Breiman, L. (1996). Bagging predictors. Machine Learning, 24(2), 123–140. https://doi.org/10.1007/BF00058655
Breiman, L. (2001). Random forests. Machine Learning, 45(1), 5–32. https://doi.org/10.1023/a:1010933404324
Brier, G. W. (1950). Verification of forecasts expressed in terms of probability. Monthly Weather Review, 78(1), 1–3. https://doi.org/10.1175/1520-0493(1950)078%3C0001:VOFEIT%3E2.0.CO;2
Briggs, A., Claxton, K., & Sculpher, M. (2006). Decision modelling for health economic evaluation. Oxford University Press.
Campbell, B. C. V., Mitchell, P. J., Churilov, L., Yassi, N., Kleinig, T. J., Dowling, R. J., Yan, B., Bush, S. J., Dewey, H. M., Thijs, V., Scroop, R., Simpson, M., Brooks, M., Asadi, H., Wu, T. Y., Shah, D. G., Wijeratne, T., Ang, T., Miteff, F., … Davis, S. M. (2018). Tenecteplase versus alteplase before thrombectomy for ischemic stroke. New England Journal of Medicine, 378(17), 1573–1582. https://doi.org/10.1056/NEJMoa1716405
Campbell, B. C. V., Mitchell, P. J., Churilov, L., Yassi, N., Kleinig, T. J., Dowling, R. J., Yan, B., Bush, S. J., Thijs, V., Scroop, R., Simpson, M., Brooks, M., Asadi, H., Wu, T. Y., Shah, D. G., Wijeratne, T., Zhao, H., Alemseged, F., Ng, F., … D’Este, C. (2020). Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke. JAMA, 323(13), 1257. https://doi.org/10.1001/jama.2020.1511
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., Doré, C. J., Parulekar, W. R., Summerskill, W. S. M., Groves, T., Schulz, K. F., Sox, H. C., Rockhold, F. W., Rennie, D., & Moher, D. (2013). SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Annals of Internal Medicine, 158(3), 200–207. https://doi.org/10.7326/0003-4819-158-3-201302050-00583
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of chronic diseases, 40(5), 373–83. https://doi.org/10.1016/0021-9681(87)90171-8
Chernozhukov, V., Chetverikov, D., Demirer, M., Duflo, E., Hansen, C., Newey, W., & Robins, J. (2018). Double/debiased machine learning for treatment and structural parameters. The Econometrics Journal, 21(1), C1–C68. https://doi.org/10.1111/ectj.12097
Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20(1), 37–46. https://doi.org/10.1177/001316446002000104
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015). Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. Annals of Internal Medicine, 162(1), 55–63. https://doi.org/10.7326/M14-0697
Cortes, C., & Vapnik, V. (1995). Support-vector networks. Machine Learning, 20(3), 273–297. https://doi.org/10.1007/BF00994018
Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society Series B: Statistical Methodology, 34(2), 187–202. https://doi.org/10.1111/j.2517-6161.1972.tb00899.x
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297–334. https://doi.org/10.1007/bf02310555
Dalkey, N., & Helmer, O. (1963). An experimental application of the Delphi method to the use of experts. Management Science, 9(3), 458–467. https://doi.org/10.1287/mnsc.9.3.458
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., Schroeder, T. V., Sox, H. C., & Van Der Weyden, M. B. (2004). Clinical trial registration: A statement from the International Committee of Medical Journal Editors. New England Journal of Medicine, 351(12), 1250–1251. https://doi.org/10.1056/NEJMe048225
Delgado-Rodríguez, M., & Llorca, J. (2004). Bias. Journal of Epidemiology & Community Health, 58(8), 635–641. https://doi.org/10.1136/jech.2003.008466
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188. https://doi.org/10.1016/0197-2456(86)90046-2
Dias, S., Welton, N. J., Caldwell, D. M., & Ades, A. E. (2010). Checking consistency in mixed treatment comparison meta‐analysis. Statistics in Medicine, 29(7-8), 932–944. https://doi.org/10.1002/sim.3767
Dimick, J. B., & Ryan, A. M. (2014). Methods for evaluating changes in health care policy: The difference-in-differences approach. JAMA, 312(22), 2401–2. https://doi.org/10.1001/jama.2014.16153
Dohoo, I. R., Martin, S. W., & Stryhn, H. (2012). Methods in Epidemiologic Research. VER Inc.
Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes (4th ed.). Oxford University Press.
Efron, B. (1979). Bootstrap methods: Another look at the jackknife. The Annals of Statistics, 7(1). https://doi.org/10.1214/aos/1176344552
El Emam, K., Jonker, E., Arbuckle, L., & Malin, B. (2011). A systematic review of re-identification attacks on health data. PLoS ONE, 6(12), e28071. https://doi.org/10.1371/journal.pone.0028071
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998). Comorbidity measures for use with administrative data. Medical care, 36(1), 8–27. https://doi.org/10.1097/00005650-199801000-00004
Emanuel, E. J., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? JAMA, 283(20), 2701–2711. https://doi.org/10.1001/jama.283.20.2701
Farrington, C. P. (1995). Relative incidence estimation from case series for vaccine safety evaluation. Biometrics, 51(1), 228–35.
Fellegi, I. P., & Sunter, A. B. (1969). A theory for record linkage. Journal of the American Statistical Association, 64(328), 1183–1210. https://doi.org/10.1080/01621459.1969.10501049
Fine, J. P., & Gray, R. J. (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496–509. https://doi.org/10.1080/01621459.1999.10474144
Firth, D. (1993). Bias reduction of maximum likelihood estimates. Biometrika, 80(1), 27–38. https://doi.org/10.1093/biomet/80.1.27
Friedman, J. H. (2001). Greedy function approximation: A gradient boosting machine. The Annals of Statistics, 29(5), 1189–1232. https://doi.org/10.1214/aos/1013203451
Gamble, C., Krishan, A., Stocken, D., Lewis, S., Juszczak, E., Doré, C., Williamson, P. R., Altman, D. G., Montgomery, A., Lim, P., Berlin, J., Senn, S., Day, S., Barbachano, Y., & Loder, E. (2017). Guidelines for the content of statistical analysis plans in clinical trials. JAMA, 318(23), 2337–2343. https://doi.org/10.1001/jama.2017.18556
Gelman, A. (2006). Prior distributions for variance parameters in hierarchical models. Bayesian Analysis, 1(3), 515–534. https://doi.org/10.1214/06-BA117A
Gelman, A., Carlin, J. B., Stern, H. S., Dunson, D. B., Vehtari, A., & Rubin, D. B. (2013). Bayesian data analysis (3rd ed.). CRC Press. https://doi.org/10.1201/b16018
Geman, S., & Geman, D. (1984). Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images. IEEE Transactions on Pattern Analysis and Machine Intelligence, 6(6), 721–741. https://doi.org/10.1109/TPAMI.1984.4767596
Greenland, S., Senn, S. J., Rothman, K. J., Carlin, J. B., Poole, C., Goodman, S. N., & Altman, D. G. (2016). Statistical tests, P values, confidence intervals, and power: A guide to misinterpretations. European Journal of Epidemiology, 31(4), 337–350. https://doi.org/10.1007/s10654-016-0149-3
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008). GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336(7650), 924–926. https://doi.org/10.1136/bmj.39489.470347.AD
Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29–36. https://doi.org/10.1148/radiology.143.1.7063747
Hastie, T., Tibshirani, R., & Friedman, J. (2009). The elements of statistical learning: Data mining, inference, and prediction (2nd ed.). Springer. https://doi.org/10.1007/978-0-387-84858-7
Hastings, W. K. (1970). Monte Carlo sampling methods using Markov chains and their applications. Biometrika, 57(1), 97–109. https://doi.org/10.1093/biomet/57.1.97
Hernán, M. A., & Robins, J. M. (2016). Using big data to emulate a target trial when a randomized trial is not available. American Journal of Epidemiology, 183(8), 758–764. https://doi.org/10.1093/aje/kwv254
Hernán, M. A., & Robins, J. M. (2020). Causal Inference: What If. Boca Raton, FL: Chapman & Hall/CRC.
Hill, A. B. (1965). The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, 58(5), 295–300. https://doi.org/10.1177/003591576505800503
Hoerl, A. E., & Kennard, R. W. (1970). Ridge regression: Biased estimation for nonorthogonal problems. Technometrics, 12(1), 55–67. https://doi.org/10.1080/00401706.1970.10488634
Hoffman, M. D., & Gelman, A. (2014). The No-U-Turn sampler: Adaptively setting path lengths in Hamiltonian Monte Carlo. Journal of Machine Learning Research, 15(1), 1593–1623.
Hosmer, D. W., & Lemeshow, S. (1980). Goodness of fit tests for the multiple logistic regression model. Communications in Statistics – Theory and Methods, 9(10), 1043–1069. https://doi.org/10.1080/03610928008827941
Hripcsak, G., Duke, J. D., Shah, N. H., Reich, C. G., Huser, V., Schuemie, M. J., Suchard, M. A., Park, R. W., Wong, I. C. K., Rijnbeek, P. R., van der Lei, J., Pratt, N., Norén, G. N., Li, Y.-C., Stang, P. E., Madigan, D., & Ryan, P. B. (2015). Observational Health Data Sciences and Informatics (OHDSI): Opportunities for observational researchers. Studies in Health Technology and Informatics, 216, 574–578.
Huber, P. J. (1964). Robust estimation of a location parameter. The Annals of Mathematical Statistics, 35(1), 73–101. https://doi.org/10.1214/aoms/1177703732
Huber, P. J. (1967). The behavior of maximum likelihood estimates under nonstandard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, 1, 221–233.
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., Mauskopf, J., Mullins, C. D., Petrou, S., Pwu, R.-F., & Staniszewska, S. (2022). Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement. BMJ, 376, e067975. https://doi.org/10.1136/bmj-2021-067975
ICH E9 Expert Working Group. (1999). Statistical principles for clinical trials: ICH harmonised tripartite guideline E9. Statistics in Medicine, 18(15), 1905–1942.
ICH E6 Expert Working Group. (2016). Integrated addendum to ICH E6(R1): Guideline for good clinical practice E6(R2). International Council for Harmonisation. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf
Johnson, K. C., Whelton, P. K., Cushman, W. C., Cutler, J. A., Evans, G. W., Snyder, J. K., Ambrosius, W. T., Beddhu, S., Cheung, A. K., Fine, L. J., Lewis, C. E., Rahman, M., Reboussin, D. M., Rocco, M. V., Oparil, S., & Wright, J. T. (2018). Blood pressure measurement in SPRINT (Systolic blood pressure intervention trial). Hypertension, 71(5), 848–857. https://doi.org/10.1161/HYPERTENSIONAHA.117.10479
Jolliffe, I. T. (2002). Principal component analysis (2nd ed.). Springer. https://doi.org/10.1007/b98835
Kass, R. E., & Raftery, A. E. (1995). Bayes factors. Journal of the American Statistical Association, 90(430), 773–795. https://doi.org/10.1080/01621459.1995.10476572
Kish, L. (1965). Survey Sampling. New York, NY: John Wiley & Sons.
Krieger, N. (1994). Epidemiology and the web of causation: Has anyone seen the spider? Social Science & Medicine, 39(7), 887–903. https://doi.org/10.1016/0277-9536(94)90202-x
Latimer, N. R. (2013). Survival analysis for economic evaluations alongside clinical trials—Extrapolation with patient-level data: Inconsistencies, limitations, and a practical guide. Medical Decision Making, 33(6), 743–754. https://doi.org/10.1177/0272989X12472398
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988). An assessment of clinically useful measures of the consequences of treatment. The New England journal of medicine, 318(26), 1728–33. https://doi.org/10.1056/nejm198806303182605
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010). Negative controls: A tool for detecting confounding and bias in observational studies. Epidemiology, 21(3), 383–388. https://doi.org/10.1097/EDE.0b013e3181d61eeb
Lloyd, S. (1982). Least squares quantization in PCM. IEEE Transactions on Information Theory, 28(2), 129–137. https://doi.org/10.1109/TIT.1982.1056489
Logallo, N., Novotny, V., Assmus, J., Kvistad, C. E., Alteheld, L., Rønning, O. M., Thommessen, B., Amthor, K. F., Ihle-Hansen, H., Kurz, M., Tobro, H., Kaur, K., Stankiewicz, M., Carlsson, M., Morsund, Idicula, T., Aamodt, A. H., Lund, C., Næss, H., … Thomassen, L. (2017). Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): A phase 3, randomised, open-label, blinded endpoint trial. The Lancet Neurology, 16(10), 781–788. https://doi.org/10.1016/S1474-4422(17)30253-3
Menon, B. K., Buck, B. H., Singh, N., Deschaintre, Y., Almekhlafi, M. A., Coutts, S. B., Thirunavukkarasu, S., Khosravani, H., Appireddy, R., Moreau, F., Gubitz, G., Tkach, A., Catanese, L., Dowlatshahi, D., Medvedev, G., Mandzia, J., Pikula, A., Shankar, J., Williams, H., … Aljundi, Z. E. (2022). Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): A pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. The Lancet, 400(10347), 161–169. https://doi.org/10.1016/S0140-6736(22)01054-6
Mihaylova, B., Briggs, A., O’Hagan, A., & Thompson, S. G. (2011). Review of statistical methods for analysing healthcare resources and costs. Health Economics, 20(8), 897–916. https://doi.org/10.1002/hec.1653
Morgenstern, H. (1982). Uses of ecologic analysis in epidemiologic research. American Journal of Public Health, 72(12), 1336–1344. https://doi.org/10.2105/ajph.72.12.1336
Morris, T. P., White, I. R., & Crowther, M. J. (2019). Using simulation studies to evaluate statistical methods. Statistics in Medicine, 38(11), 2074–2102. https://doi.org/10.1002/sim.8086
Muir, K. W., Ford, G. A., Ford, I., Wardlaw, J. M., McConnachie, A., Greenlaw, N., Mair, G., Sprigg, N., Price, C. I., MacLeod, M. J., Dima, S., Venter, M., Zhang, L., O’Brien, E., Sanyal, R., Reid, J., Sztriha, L. K., Haider, S., Whiteley, W. N., … ATTEST-2 Investigators (2024). Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): A randomised, parallel group, open-label trial. The Lancet Neurology, 23(11), 1087–1096. https://doi.org/10.1016/S1474-4422(24)00377-6
O’Quigley, J., Pepe, M., & Fisher, L. (1990). Continual reassessment method: A practical design for phase 1 clinical trials in cancer. Biometrics, 46(1), 33. https://doi.org/10.2307/2531628
Peng, R. D. (2011). Reproducible research in computational science. Science, 334(6060), 1226–1227. https://doi.org/10.1126/science.1213847
Piaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., & Altman, D. G. (2012). Reporting of noninferiority and equivalence randomized trials: Extension of the CONSORT 2010 statement. JAMA, 308(24), 2594–2604. https://doi.org/10.1001/jama.2012.87802
Pocock, S. J., & Simon, R. (1975). Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics, 31(1), 103. https://doi.org/10.2307/2529712
Popper, K. R. (1959). The Logic of Scientific Discovery. Hutchinson.
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., Jauch, E. C., Kidwell, C. S., Leslie-Mazwi, T. M., Ovbiagele, B., Scott, P. A., Sheth, K. N., Southerland, A. M., Summers, D. V., Tirschwell, D. L., & American Heart Association Stroke Council (2019). Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 50(12). https://doi.org/10.1161/STR.0000000000000211
Prabhakaran, S., Gonzalez, N. R., Zachrison, K. S., Adeoye, O., Alexandrov, A. W., Ansari, S. A., Chapman, S., Czap, A. L., Dumitrascu, O. M., Ishida, K., Jadhav, A. P., Johnson, B., Johnston, K. C., Khatri, P., Kimberly, W. T., Lee, V. H., Leslie-Mazwi, T. M., Mac Grory, B., Madsen, T. E., … Yaghi, S. (2026). 2026 guideline for the early management of patients with acute ischemic stroke: A guideline from the American Heart Association/American Stroke Association. Stroke. Advance online publication. https://doi.org/10.1161/STR.0000000000000513
Prasad, V., & Jena, A. B. (2013). Prespecified falsification end points: Can they validate true observational associations? JAMA, 309(3), 241–242. https://doi.org/10.1001/jama.2012.96867
Robins, J. M., & Greenland, S. (1992). Identifiability and exchangeability for direct and indirect effects. Epidemiology (Cambridge, Mass.), 3(2), 143–55. https://doi.org/10.1097/00001648-199203000-00013
Robins, J. M., Hernán, M. A., & Brumback, B. (2000). Marginal structural models and causal inference in epidemiology. Epidemiology (Cambridge, Mass.), 11(5), 550–60. https://doi.org/10.1097/00001648-200009000-00011
Rose, D., Cavalier, A., Kam, W., Cantrell, S., Lusk, J., Schrag, M., Yaghi, S., Stretz, C., de Havenon, A., Saldanha, I. J., Wu, T. Y., Ranta, A., Barber, P. A., Marriott, E., Feng, W., Kosinski, A. S., Laskowitz, D., Poli, S., & Mac Grory, B. (2023). Complications of intravenous tenecteplase versus alteplase for the treatment of acute ischemic stroke: A systematic review and meta-analysis. Stroke, 54(5), 1192–1204. https://doi.org/10.1161/STROKEAHA.122.042335
Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. https://doi.org/10.1093/biomet/70.1.41
Rothman, K. J., & Greenland, S. (2005). Causation and causal inference in epidemiology. American Journal of Public Health, 95(S1), S144–S150. https://doi.org/10.2105/ajph.2004.059204
Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins.
Royston, P., & Parmar, M. K. (2013). Restricted mean survival time: An alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC Medical Research Methodology, 13(1). https://doi.org/10.1186/1471-2288-13-152
Rubin, D. B. (1976). Inference and missing data. Biometrika, 63(3), 581–592. https://doi.org/10.1093/biomet/63.3.581
Salanti, G., Ades, A. E., & Ioannidis, J. P. (2011). Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: An overview and tutorial. Journal of clinical epidemiology, 64(2), 163–71. https://doi.org/10.1016/j.jclinepi.2010.03.016
Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., Salomon, J. A., Sculpher, M. J., Trikalinos, T. A., Russell, L. B., Siegel, J. E., & Ganiats, T. G. (2016). Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-Effectiveness in Health and Medicine. JAMA, 316(10), 1093–1103. https://doi.org/10.1001/jama.2016.12195
Schulz, K. F., & Grimes, D. A. (2002). Allocation concealment in randomised trials: Defending against deciphering. The Lancet, 359(9306), 614–618. https://doi.org/10.1016/S0140-6736(02)07750-4
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. https://doi.org/10.1136/bmj.c332
Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86(2), 420–428. https://doi.org/10.1037/0033-2909.86.2.420
Simon, R. (1989). Optimal two-stage designs for phase II clinical trials. Controlled clinical trials, 10(1), 1–10. https://doi.org/10.1016/0197-2456(89)90015-9
Simonsohn, U., Simmons, J. P., & Nelson, L. D. (2020). Specification curve analysis. Nature Human Behaviour, 4(11), 1208–1214. https://doi.org/10.1038/s41562-020-0912-z
Singh, A., Singh, M. P., Gaikwad, N. R., & Kannauje, P. K. (2024). Tenecteplase versus alteplase in acute ischemic stroke: A systematic review and meta-analysis. Annals of Neurosciences, 31(2), 132–142. https://doi.org/10.1177/09727531231193242
Sterne, J. A. C., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., … Higgins, J. P. T. (2016). ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ, 355, i4919. https://doi.org/10.1136/bmj.i4919
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., … Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. https://doi.org/10.1136/bmj.l4898
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010). Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology, 21(1), 128–138. https://doi.org/10.1097/EDE.0b013e3181c30fb2
Stinnett, A. A., & Mullahy, J. (1998). Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making, 18(2 Suppl), S68–S80. https://doi.org/10.1177/0272989X98018002S09
Stone, M. (1974). Cross-validatory choice and assessment of statistical predictions. Journal of the Royal Statistical Society Series B: Statistical Methodology, 36(2), 111–147. https://doi.org/10.1111/j.2517-6161.1974.tb00994.x
Sullivan, S. D., Mauskopf, J. A., Augustovski, F., Caro, J. J., Lee, K. M., Minchin, M., Orlewska, E., Penna, P., Rodriguez Barrios, J.-M., & Shau, W.-Y. (2014). Budget impact analysis—Principles of good practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health, 17(1), 5–14. https://doi.org/10.1016/j.jval.2013.08.2291
Thabane, L., Mbuagbaw, L., Zhang, S., Samaan, Z., Marcucci, M., Ye, C., Thabane, M., Giangregorio, L., Dennis, B., Kosa, D., Borg Debono, V., Dillenburg, R., Fruci, V., Bawor, M., Lee, J., Wells, G., & Goldsmith, C. H. (2013). A tutorial on sensitivity analyses in clinical trials: The what, why, when and how. BMC Medical Research Methodology, 13, 92. https://doi.org/10.1186/1471-2288-13-92
The SPRINT Research Group (2015). A randomized trial of intensive versus standard blood-pressure control. New England Journal of Medicine, 373(22), 2103–2116. https://doi.org/10.1056/NEJMoa1511939
The SPRINT Research Group (2021). Final report of a trial of intensive versus standard blood-pressure control. New England Journal of Medicine, 384(20), 1921–1930. https://doi.org/10.1056/NEJMoa1901281
Thistlethwaite, D. L., & Campbell, D. T. (1960). Regression-discontinuity analysis: An alternative to the ex post facto experiment. Journal of Educational Psychology, 51(6), 309–317. https://doi.org/10.1037/h0044319
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B: Statistical Methodology, 58(1), 267–288. https://doi.org/10.1111/j.2517-6161.1996.tb02080.x
Tsiatis, A. A. (2006). Semiparametric Theory and Missing Data. New York, NY: Springer.
van der Laan, M. J., & Rubin, D. (2006). Targeted maximum likelihood learning. The International Journal of Biostatistics, 2(1). https://doi.org/10.2202/1557-4679.1043
VanderWeele, T. J., & Ding, P. (2017). Sensitivity analysis in observational research: Introducing the E-value. Annals of Internal Medicine, 167(4), 268–274. https://doi.org/10.7326/m16-2607
Vickers, A. J., & Elkin, E. B. (2006). Decision curve analysis: A novel method for evaluating prediction models. Medical decision making : an international journal of the Society for Medical Decision Making, 26(6), 565–74. https://doi.org/10.1177/0272989x06295361
Wang, Y., Li, S., Pan, Y., Li, H., Parsons, M. W., Campbell, B. C. V., Schwamm, L. H., Fisher, M., Che, F., Dai, H., Li, D., Li, R., Wang, J., Wang, Y., Zhao, X., Li, Z., Zheng, H., Xiong, Y., Meng, X., & TRACE-2 Investigators (2023). Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): A phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. The Lancet, 401(10377), 645–654. https://doi.org/10.1016/S0140-6736(22)02600-9
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., … Wright, J. T. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension, 71(6). https://doi.org/10.1161/HYP.0000000000000065
Yao, B., Wang, X., Wu, Y., Zhu, Q., Li, L., Tang, X., & Wu, M. (2025). Tenecteplase versus alteplase for intravenous thrombolysis of acute ischemic stroke patients with large-vessel occlusion: A systematic review and meta-analysis. Frontiers in Neurology, 16. https://doi.org/10.3389/fneur.2025.1487711
Youden, W. J. (1950). Index for rating diagnostic tests. Cancer, 3(1), 32–35. https://doi.org/10.1002/1097-0142(1950)3:1%3C32::AID-CNCR2820030106%3E3.0.CO;2-3
Zou, H., & Hastie, T. (2005). Regularization and variable selection via the elastic net. Journal of the Royal Statistical Society Series B: Statistical Methodology, 67(2), 301–320. https://doi.org/10.1111/j.1467-9868.2005.00503.x